Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764270 · ClinicalTrials.gov registry record · Phase 2
The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease
A Phase 2 study, sponsored by Oregon State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT00764270: Completed Phase 2 study, sponsored by Oregon State University.
NCT00764270 is a Phase 2 study that has completed, run by Oregon State University. The registered enrollment target is 28 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764270, a Phase 2 study, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a dietary supplement, R-alpha lipoic acid, is able to reduce risk factors in people with documented heart disease and increased levels of inflammation.
Primary Outcome
High sensitive C-reactive protein
Interventions
- DIETARY_SUPPLEMENT R-alpha lipoic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-08-01 |
| Est. Completion | 2024-10-01 |
| Phase | Phase 2 |
What the finished NCT00764270 record still lists
NCT00764270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which R-alpha lipoic acid is the first listed.
NCT00764270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00764270 about?
NCT00764270 is a clinical study titled "The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease". The purpose of this study is to see if a dietary supplement, R-alpha lipoic acid, is able to reduce risk factors in people with documented heart disease and increased levels of inflammation.
What is the current status of trial NCT00764270?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2011-08-01. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT00764270?
The interventions under investigation include: R-alpha lipoic acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00764270?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00764270's enrollment target sits among peer trials
28 1677th of 2000 higher than 304 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI